Basically, they are saying ACE/ARB inhibitors actually increase ACE2 receptors, which COVID-19 (basically a turbo charged SARS) and SARS from 2002 enter the cell via the ACE2 receptor, which are mainly in the lungs, but also in the heart and GI track. Once they attach, then they release its RNA...